Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Consider, if $20.00 was borrowed into existence with10% interest due in a year.
One year out, $22.00 is required to repay it.
Where does that $22.00 come from?
It has to be borrowed, with interest.
And this goes on and on.... and has been...
However the government is OPPOSITE! We NEED to create more and more debt to keep the system operating. We have to, as a govt, create more debt/money to cover the interest on previously borrowed principal. You see smarty pants, only the principal was borrowed into existence, not the interest. So where does the money come from to pay the interest? Answer that! We have to borrow it into existence.
*
Nailed it !
>>>>So where does the money come from to pay the interest? Answer that! We have to borrow it into existence.<<<<
As I read it, just (ahem !) yet another 'proof of concept' study.
I thought Dr S. was busy with Phase 1 to prove this molecule was safe for hew-mons ?
That seems to be 'tabled' forever...
*
MTAs that vaporized to nothing.
Eye drops that have gone...well ...no where...
Lip balm that never got started...
Any other study seemingly just stalled in progress..
Etc...
*
but of course...
The flippers and daytraders are / have driven this down..
No easy $
Hmmm....
Let me think here...
1) no munny.
2) no product.
3) no revenue.
4) research stalled - it seems so..
5) no updates / PRs
6) still above a penny - miracle !
7) safe for hew-mons, ie passed Phase 1 in ANY modality ?
Still up if invested back in 2012/2013.
...Whered all the munny go ?
...Mebbe ?
As always DYOR...
Yup.
that's some DD.
*
...has never cleared the hurdle of Phase 1 in anything.
*
Kaput
*
How does it stay above a penny ?!
That's the miracle !
Yep, classy dude.
..It could be argued, they're already worthless.
*
Patents that 'do' what zactly ?
Any 'proof' they actually 'do' anything ?
'IF' they do anything, is it commercially viable..?
And so on...
*
Cure blindness of rodents ...?
ONE, study said so, but no one anywhere (entire planet) is interested in verifying.
Even the guy who, authored the study is not interested (apparently) in pursuing any more usefulness of the miracle molecule..
*
Kaput - imho....
*
Do your own DD.
Lachlan Grant Young, a major owner of ProtoKinetix, Inc., recently disposed of 1,125,600 shares of the company. The disposals took place at $0.00 per share, on December 13, 2022. Young still owns 10,021,250 shares of the company. Young operates out of West Vancouver Bc, A1. Some additional info was provided as follows:
Mr. Young no longer exercises control over shares owned by his wife.
Cancellation of warrants for no value received.
Warrants granted on December 13, 2022. Fully vested.
Options granted pursuant to Amended 2017 Stock Option and Stock Bonus Plan on December 7, 2022. Fully vested.
https://www.conferencecalltranscripts.org/summary/?id=11614463
Options granted pursuant to Amended 2017 Stock Option and Stock Bonus Plan on December 7, 2022. 1,500,000 options vested December 7, 2022; 500,000 options vest D ecember 31, 2022.
Link _ source ?
Yup !
*
Sumthang 'bout 3 and half cents somebody likes...
... it does show up as a whopping 4 cents on many screens until ya drill into it
(part of that painting it seems).
Mebbe it was ?
Doesn't mean it succeeded - its a possibility.
Sumthang to CONsider...
*
ORrrrrrr...
It never got going in the first place ...
Seems that happens a LOT here too..
10-Q ....from 29 July 2022
https://www.otcmarkets.com/filing/conv_pdf?id=15978629&guid=j71-k65yvZMXB3h
I agree, they have a couple of Consultants.
*
The Researchers (scientists) at the Canadian Universities (...think the ones who did short video clips for PKTX, but just said the molecule has potential) .
*Dr Shapiro: (IMO) was the leading Dr and the most advanced Clinical Study.
Not a peep from him about since - ????
* Dr Evans: Cured BLIND mice. Kinda slow on the Research Paper release for Journal publication. Seemed quite reticent about the whole ordeal really. Has shown no interest in pursuing any other major cure / treatment with the miracle molecule.
* and there was one more Canadian Dr doing a 'transplant' (organ I think) but I think we heard the least of this and it's not worth it to me to dig to find it.
**
Upshot: These were the only guys remotely interested in the molecule. They haven't said anything in a very long time. ...I don't know why. IMHO - there's only approx 2ea reasons.
*
Dry Eye / lip balm ...probably going the same way the MTAs did ....
*
..DYOR
Another oddity with this PR.
It implies / suggests at the title its completed and good.
Then when you read it, it implies they're just getting started as they've completed enrollment.
*
They (the Study) already had 6ea patients undergoing the study.
Then the study got stalled (long b4 the cuff). (At least I thought it was done and being complied for release).
Then 'they' decided that was only the first half of the study and called it 1A.
And Phase 1 would be completed at the end of Phase 1B.
Then enter the 'cuff' and the study gets to pause.
Finally there's a PR announcing the resumption of 1B and I do not recall any word about it needing a prolonged enrollment period.
*
Upshot: this is the time period we were expecting (ahem !) a positive conclusion to Phase 1.
*
That's from memory, so as always DYOR.
Amazing !
*
No Munny.
No Product.
No Revenue.
*
Business Wire PR post by PKTX:
"ProtoKinetix Successfully Completes Phase 1 Clinical Trials for the Treatment of Type 1 Diabetes in Islet Cell Transplants"
*
The first sentence of that PR:
MARIETTA, Ohio, July 20, 2022--(BUSINESS WIRE)--ProtoKinetix, Incorporated (www.protokinetix.com) (the "Company" or "ProtoKinetix") (OTCQB: PKTX), a clinical-stage biomedical company, today announced that the University of Alberta has successfully completed Phase 1 clinical trial enrollment for the treatment of type 1 diabetes in islet cell transplants.
*
....and really no research in my estimation.
As always - DYOR.
Shoor !!!
Why not ? …besides a notion that anyone who might be a customer has a $h!+ ton of work in order to monetize the molecule.
The volumes and volumes of verbose info on ihub and the (newer PKTX website) have nuthin but ‘proof of concept’ studies. NOT actual results of an actual miracle application. ….say for one sorta recent published journal study where blind mice can now see. AND that has not been peered reviewed and evidently no one (the entire planet) is interested in doing a peer review study (that is odd to me, some university somewhere has students/grad students who need to do a peer study for credits, they have the lab, etc, and would most probably get molecules from PKTX for free (as PKTX seems desperate to get anyone to notice)).
10ks also note: no munny, no product, no revenue.
This I was aware of coming in, but there was seeming a somewhat steady stream of research. Remember the videos of the Researchers yappin up the molecule and how that was to be a somewhat steady update ? Poof or just dimmed to nuthingness…
Plus, for quite sometime the Researchers haven’t said crap (even if they had a mouth full of it) about the molecule in a very long time. ..I should have noted that moreso than I did for myself… Which lead to PKTX radio silence and/or recycled PR news (that was noticed), which lead to silence again since there’s nuthin to say.
Even the blind mice study, Dr Evans(?) , why was there no PR campaign, video, etc ?
To me, it seems, for whatever reason- the researchers are no longer interested in PKTX…
…so: No munny, no product, no revenue, and for quite some time - no research ….. (and have not mentioned the Dry Eye – there’s nuthin to say, PKTX too broke, no partners, etc..)
Why is this SH above a penny then ? Patents to unproven technology or what appears to be some paint the tape activity ?
This is by far my worst OTC choice, and I have(had) others. Eg I have a position 'now' where the SP is in the trips and they have REVENUE, products, etc and have been copper.
As always DYOR.
There's that volume !
Yah.
What happened to the videos of the researchers blah-blahing 'bout the miracle molecule ? They each did like two each and it just vaporized to nothingness...
That was 'suppose' to be a somewhat regular posting of updates, as I remember it.
Kaput !
I agree...
From page 19:
"The CROs contracted by the Company for research projects have been able to meet milestone goals without disruption due to the pandemic."
*
So why not issue a PR of some of these milestones ?
Welp...
*
Not a word uttered - about anything....
*
That says MUCH.
....so borrowing this post as it's representative of the "many irons" in the fire.
*
Peeerk near the half-way mark of the year and ...well... nuthin'
*
Are the test subjects still alive ?
Are there any actual test subjects ?
When could we expect to hear something ?
Did Smith position his Linkd In next to some other Linkd In account ?
*
Just wondering....no news here is usually bad.
Just saying...
...loss of capital
... no progress on research, no updates quarterly
... I think that's a couple of good reasons.
Purdy much what I think too.
Hysterical !!!
....in previous posts of mine I had predicted this nickel SP if there weren't any accomplishments.
*
And... there haven't been any and here we are.
(Of course the overall Market tanking is a factor as well, but you get my point..?)
*
Taking an optimist angle; at least they have a plan, and a timeline.
~$3.5M (meh, call it $4M) and four or fives years and viola = $2B/yr in revenue from eye treatment sales.
*
100,000,000 shares x 6cents = $6M
There's the funds to do it.
*
Just have to puzzle out that pesky volume issue of "0" ....
I agree.
*
It is annoying, frustrating, etc that there's never any mention on the quarterly's on the progress of trial.
*
Progress = accomplishments = news.
Obviously this kind of 'news' would help the SP -imo.
*
To me, it 'feels' like Shapiro is SsssLlllOooWww walking this, and dodging Smith. Because I think Smith would post progress if he could get any updates. ...Just an impression, I don't actually know.
*
We shall see though, and hopefully this will be moot with a successful completion of this trial this year. By summer, I think ?
any updates on this ?:
MARIETTA, Ohio, November 23, 2021--(BUSINESS WIRE)--ProtoKinetix, Incorporated (www.protokinetix.com) (the "Company" or "ProtoKinetix") (OTCQB: PKTX), a clinical-stage biomedical company, today announced that it has selected two formulations of its Anti-Aging Glycopeptide (AAGP®) product to be advanced into preclinical efficacy testing for the topical treatment of dry eye disease and ocular inflammation.
The selection follows a seven-month formulation development program conducted by Catalent, in which the Active Pharmaceutical Ingredient (API) was screened for ideal formulation conditions, with a number of potential excipients, to come up with a drug product that suits ProtoKinetix’s needs. The efficacy testing will be conducted by EyeCRO of Oklahoma City. This study should be completed by mid to late January 2022. The resulting lead formulation will then undergo extensive Good Laboratory Practice (GLP) toxicology examination, to prepare a submission for the U.S. FDA for its approval to conduct clinical trials.
Good grief....
*
All I can say to this...
Well seems your crystal ball juju prediction came full circle.
*
There was just too long a drought of nothing burgers to hold the SP IMO.
It was beginning to be somewhat concerning, to me anyway.
*
Now the entire Market is in a downward trend and PKTX isn't immune from the whirlpool drag.
*
Dr Shapiro Clinical Trial should wrap up and finally launch this thing into Phase II.
Visibility into the progress of the Dry Eye bit.
*
Plus maybe we'll hear something about:
- "Working with the New Brunswick IMPART investigator team, Dr. Pulinilkunnil will lead tests on a
potential cardioprotectant molecule developed by ProtoKinetix called PKX-001 to determine its therapeutic potential for cardiac metabolism. "
- There was also a Beg-A-Thon bucket that had to be filled, and another modality could get underway. I have no idea how full the bucket is though.
*
Slow going but at least its going.
Once there's more mass ( clinical studies published in Journals, Phase II, revenue (hopefully)) it ought to gain like a downhill snowball.
*
All IMO, as always do your DD.
Agree.
*
This is what we have though.
Who knows maybe there was one and it fell through somehow or there never was one ?
*
Regardless, its moving the needle (finally).
As long as its positive it adds to the cumulative bucket of being a miracle molecule. eg: France didn't join us in the Revolutionary War until we proved we could win some major victories.
Same could be for PKTX, make some effort to "prove it" and someone will see it's legit.
Doing nuthing is dead as fried chicken for shoor though.
*
My 2cents.
Dont know anything about Mordor.
The "market research" from any source is worthy of a scoff right off the bat though.
*
Maybe some of the PPs and shares as payment get dumped.
What to do though, PKTX has no revenue ?
It's the cost of business.
*
Regardless, there is a market for eye drops.
The AAGP molecule marketing angle could be like "Cool Ranch Doritos"
of the eyedrop market world and provide PKTX with a revenue. Even at a loss to PKTX it's revenue and anyone with scale ought to be able to get a profit.
*
Combined with clinical studies in journals and Phase II hewmon trials the molecule begins to finally realize its miracle destiny.